hyperphosphatasia with mental retardation,Maps,5.057017876558194E-6
hyperphosphatasia with mental retardation,Genes,4.518119919938915E-6
hyperphosphatasia with mental retardation,Anabolism,6.244815502130002E-6
hyperphosphatasia with mental retardation,coarse facial features,0.006993006993006993
hyperphosphatasia with mental retardation,Transfection,6.512154937190266E-6
hyperphosphatasia with mental retardation,Does play,1.4418404805365954E-6
hyperphosphatasia with mental retardation,Female,1.1030697327592958E-6
hyperphosphatasia with mental retardation,CD24,7.429420505200594E-4
hyperphosphatasia with mental retardation,Coding,7.419663592452718E-6
hyperphosphatasia with mental retardation,congenital anomaly of face,6.506180871828237E-4
hyperphosphatasia with mental retardation,Subtyping,7.5486510560562825E-6
hyperphosphatasia with mental retardation,frameshift mutation function,8.336112037345781E-5
hyperphosphatasia with mental retardation,peripheral blood,3.7377728106930206E-6
hyperphosphatasia with mental retardation,Malnutrition,1.1002149086454888E-5
hyperphosphatasia with mental retardation,dating,1.3546923155078402E-5
hyperphosphatasia with mental retardation,Serum,3.250763929523438E-6
hyperphosphatasia with mental retardation,absence (morphologic abnormality),2.35094978371262E-6
hyperphosphatasia with mental retardation,maltreatment and neglect sibling as perpetrator of assault,1.1974972307876538E-4
hyperphosphatasia with mental retardation,increased serum alkaline phosphatase,0.003883495145631068
hyperphosphatasia with mental retardation,chinese hamster ovary cell,2.603895427559629E-5
hyperphosphatasia with mental retardation,consanguinity (genetic finding),2.5716857400025716E-4
hyperphosphatasia with mental retardation,severe mental retardation (i.q. 20-34),6.587615283267457E-4
hyperphosphatasia with mental retardation,severity of illness index,6.314127861089187E-6
hyperphosphatasia with mental retardation,,4.5004500450045E-4
hyperphosphatasia with mental retardation,mutations detected,7.199424046076314E-4
hyperphosphatasia with mental retardation,adolescent (age group),1.5109802937950084E-6
hyperphosphatasia with mental retardation,Syndrome,2.7324857422797518E-5
hyperphosphatasia with mental retardation,Synthesis activity,6.16180910715386E-6
hyperphosphatasia with mental retardation,hypoplastic terminal phalanges,0.05555555555555555
hyperphosphatasia with mental retardation,phosphoric monoester hydrolase activity,8.27084252315836E-5
hyperphosphatasia with mental retardation,gene duplication abnormality,3.109549426288131E-5
hyperphosphatasia with mental retardation,Seizures,2.5904051393637967E-5
hyperphosphatasia with mental retardation,Disease Screening,5.371434710211097E-6
hyperphosphatasia with mental retardation,Clinical variability,9.233610341643582E-4
hyperphosphatasia with mental retardation,intractable Seizures,8.396305625524769E-4
hyperphosphatasia with mental retardation,Hirschsprung Disease,2.2172949002217295E-4
hyperphosphatasia with mental retardation,phosphoglycerate dehydrogenase activity,3.356369214039021E-6
hyperphosphatasia with mental retardation,Epilepsy,2.7695077200027697E-5
hyperphosphatasia with mental retardation,encephalopathy adverse event,7.695267410542516E-5
hyperphosphatasia with mental retardation,multiple congenital anomalies,1.7187446289230346E-4
hyperphosphatasia with mental retardation,deficiency,2.029467873523562E-5
hyperphosphatasia with mental retardation,Cells,5.087316150753457E-7
hyperphosphatasia with mental retardation,hypoplasia of the distal phalanges,0.034482758620689655
hyperphosphatasia with mental retardation,Congenital Abnormality,3.085086690936015E-6
hyperphosphatasia with mental retardation,abnormalities,7.256025221943671E-6
hyperphosphatasia with mental retardation,Homo sapiens,5.60585722386178E-7
hyperphosphatasia with mental retardation,Encephalopathies,7.695267410542516E-5
hyperphosphatasia with mental retardation,pakistani (ethnic group),3.6310820624546115E-4
hyperphosphatasia with mental retardation,Mapping (action),5.056378621631188E-6
hyperphosphatasia with mental retardation,member,4.120805535065995E-6
hyperphosphatasia with mental retardation,Human cells,4.218519299725796E-5
hyperphosphatasia with mental retardation,matching,1.0027575833542242E-5
hyperphosphatasia with mental retardation,Anorectal atresia,6.83526999316473E-4
hyperphosphatasia with mental retardation,Laboratory Procedures,1.2923845593647153E-6
hyperphosphatasia with mental retardation,serum alkaline phosphatase measurement,3.3344448149383126E-4
hyperphosphatasia with mental retardation,encoding mental process,6.13489405037975E-6
hyperphosphatasia with mental retardation,Models, Molecular,5.309913076722934E-6
hyperphosphatasia with mental retardation,Tissue membrane,3.833951558022064E-6
hyperphosphatasia with mental retardation,Developmental Disabilities,1.1502846954621269E-4
hyperphosphatasia with mental retardation,congenital anomaly of the kidney,0.0011363636363636363
hyperphosphatasia with mental retardation,pathogenicity,2.5074596925854416E-5
hyperphosphatasia with mental retardation,amino acid sequence,4.618457666062418E-6
hyperphosphatasia with mental retardation,Saudi Arabia,9.530162965786715E-5
hyperphosphatasia with mental retardation,Psychomotor delay,0.0027397260273972603
hyperphosphatasia with mental retardation,Physiological Processes,3.0901393652853744E-5
hyperphosphatasia with mental retardation,Hemoglobinuria, Paroxysmal,5.521811154058532E-4
hyperphosphatasia with mental retardation,Pedigree,6.134028523232633E-5
hyperphosphatasia with mental retardation,Animals,2.3469363327805515E-7
hyperphosphatasia with mental retardation,Child, Preschool,8.748095102291476E-6
hyperphosphatasia with mental retardation,DNA Sequence,7.74232309953066E-6
hyperphosphatasia with mental retardation,Patients,7.428666232502395E-7
hyperphosphatasia with mental retardation,Case Reports,4.911518985476638E-6
hyperphosphatasia with mental retardation,general (procedure) toxicology screen,5.375505969499379E-6
hyperphosphatasia with mental retardation,Mother (person),4.693117074498541E-6
hyperphosphatasia with mental retardation,atherogenic lipoprotein phenotype,2.0381127076327322E-4
hyperphosphatasia with mental retardation,Impaired health,8.362742310458446E-6
hyperphosphatasia with mental retardation,Hamsters,1.0880800826940862E-5
hyperphosphatasia with mental retardation,Family,9.934057724822628E-6
hyperphosphatasia with mental retardation,Cohort,1.0073486080960608E-5
hyperphosphatasia with mental retardation,CD55,4.894762604013706E-4
hyperphosphatasia with mental retardation,,0.041666666666666664
hyperphosphatasia with mental retardation,single nucleotide polymorphism,1.244818443230055E-5
hyperphosphatasia with mental retardation,malformations,3.038774766014343E-5
hyperphosphatasia with mental retardation,defects,4.453113171418138E-6
hyperphosphatasia with mental retardation,entire distal phalanx,7.283321194464676E-4
hyperphosphatasia with mental retardation,Refractory epilepsy,2.147766323024055E-4
hyperphosphatasia with mental retardation,dideoxy chain termination dna sequencing,6.226650062266501E-4
hyperphosphatasia with mental retardation,Homozygote,2.8823427682019945E-5
hyperphosphatasia with mental retardation,Elevation procedure,7.93241581723714E-6
hyperphosphatasia with mental retardation,Infant,8.797473365649386E-6
hyperphosphatasia with mental retardation,United States,1.8149380289410018E-6
hyperphosphatasia with mental retardation,Cricetulus,4.8035354020559135E-5
hyperphosphatasia with mental retardation,receptors, cell surface,1.5695630336514316E-5
hyperphosphatasia with mental retardation,Pakistan,8.438818565400843E-5
hyperphosphatasia with mental retardation,Screening procedure,5.300259712725924E-6
hyperphosphatasia with mental retardation,Autosome,3.8712424752724385E-5
hyperphosphatasia with mental retardation,Muscle hypotonia,1.7352073572791948E-4
hyperphosphatasia with mental retardation,Phenotype,2.8823843082998255E-6
hyperphosphatasia with mental retardation,sibling,1.1972104995360809E-4
hyperphosphatasia with mental retardation,Golgi Apparatus,3.6871796762656245E-5
hyperphosphatasia with mental retardation,Relationship - Sibling,1.1726422561637009E-4
hyperphosphatasia with mental retardation,phosphorus metabolism disorders,0.009146341463414634
hyperphosphatasia with mental retardation,enzymology,3.3787208162989493E-6
hyperphosphatasia with mental retardation,Growth pattern,9.975062344139652E-5
hyperphosphatasia with mental retardation,Infantile spasms,3.252032520325203E-4
hyperphosphatasia with mental retardation,,3.362474781439139E-5
hyperphosphatasia with mental retardation,developmental delay (disorder),1.0239606799098914E-4
hyperphosphatasia with mental retardation,Mutation Abnormality,1.2064424024289706E-5
hyperphosphatasia with mental retardation,Pgap2,0.26666666666666666
hyperphosphatasia with mental retardation,Experimental Finding,7.981575331504754E-7
hyperphosphatasia with mental retardation,Anchoring procedure,1.2119743061447097E-4
hyperphosphatasia with mental retardation,anchoring activity,1.2120844822884154E-4
hyperphosphatasia with mental retardation,development aspects,8.767100228996658E-7
hyperphosphatasia with mental retardation,Speech,1.876771202822664E-5
hyperphosphatasia with mental retardation,seizure adverse event,2.7544794722417333E-5
hyperphosphatasia with mental retardation,Male gender,7.236111234225504E-7
hyperphosphatasia with mental retardation,,4.82322866927121E-5
hyperphosphatasia with mental retardation,,5.230125523012552E-4
hyperphosphatasia with mental retardation,bioformation,5.202913631633715E-5
hyperphosphatasia with mental retardation,severe developmental delay,0.009569377990430622
hyperphosphatasia with mental retardation,Child,4.116202029781545E-6
hyperphosphatasia with mental retardation,sequence homology, amino acid,1.0118385105737124E-5
hyperphosphatasia with mental retardation,molecular sequence data,3.3159467193681134E-6
hyperphosphatasia with mental retardation,Base Sequence,5.923946011525629E-6
hyperphosphatasia with mental retardation,protein sequence determination,4.617188870727946E-6
hyperphosphatasia with mental retardation,PIGW,0.02702702702702703
hyperphosphatasia with mental retardation,alkaline phosphatase level - finding,7.94912559618442E-4
hyperphosphatasia with mental retardation,Diagnosis,1.8572930325509178E-6
hyperphosphatasia with mental retardation,See,1.7707200810281509E-6
hyperphosphatasia with mental retardation,normal assessment finding,1.0067766133846923E-6
hyperphosphatasia with mental retardation,recessive inheritance,3.779289493575208E-4
hyperphosphatasia with mental retardation,nonsense-mediated decay,0.0016863406408094434
hyperphosphatasia with mental retardation,Blood Cells,3.964478274659055E-5
hyperphosphatasia with mental retardation,Psychomotor Performance,2.060071690494829E-5
hyperphosphatasia with mental retardation,parent,9.399026260879374E-6
hyperphosphatasia with mental retardation,Heterozygote,3.807589795659348E-5
hyperphosphatasia with mental retardation,In Blood,4.209170519811513E-6
hyperphosphatasia with mental retardation,Electroencephalography,1.078911593983989E-5
hyperphosphatasia with mental retardation,Rectum,2.7523188286131065E-5
hyperphosphatasia with mental retardation,missense mutation abnormality,1.157340431687981E-4
hyperphosphatasia with mental retardation,RNA Splicing,2.0426505433450444E-5
hyperphosphatasia with mental retardation,hyperphosphatasia with mental retardation,1.0
hyperphosphatasia with mental retardation,hyperphosphatemia,3.6536353671903543E-4
hyperphosphatasia with mental retardation,Anatomical maturation,1.1669973159061735E-5
hyperphosphatasia with mental retardation,postnatal Microcephaly,0.01818181818181818
hyperphosphatasia with mental retardation,Pakistani race,3.633720930232558E-4
hyperphosphatasia with mental retardation,Entire rectum,2.8029262550102307E-5
hyperphosphatasia with mental retardation,family health status,4.7762334622916366E-5
hyperphosphatasia with mental retardation,Date Fruit,1.3542795232936078E-5
hyperphosphatasia with mental retardation,Pathogenicity,4.467476769120801E-5
hyperphosphatasia with mental retardation,Encode (action),6.134442440526581E-6
hyperphosphatasia with mental retardation,Mental Retardation,2.0735057798973615E-4
hyperphosphatasia with mental retardation,,5.1432392120557526E-5
hyperphosphatasia with mental retardation,Fatal Outcome,1.8743439796071373E-5
hyperphosphatasia with mental retardation,Dates,1.3546923155078402E-5
hyperphosphatasia with mental retardation,Face,2.2532545445327594E-5
hyperphosphatasia with mental retardation,Missense Mutation,6.382028208564682E-5
hyperphosphatasia with mental retardation,Facies,2.4021138601969732E-4
hyperphosphatasia with mental retardation,cell growth pattern,9.897070467141726E-5
hyperphosphatasia with mental retardation,asian continental ancestry group,3.0672964848782285E-5
hyperphosphatasia with mental retardation,european continental ancestry group,2.3242841204908887E-5
hyperphosphatasia with mental retardation,Unrelated (finding),3.654659081218707E-5
hyperphosphatasia with mental retardation,Abnormality,7.279583316650955E-6
hyperphosphatasia with mental retardation,Chromosome Mapping,1.2486576929800464E-5
hyperphosphatasia with mental retardation,Biochemical Pathway,1.006125290770209E-5
hyperphosphatasia with mental retardation,Mutant,3.156984196137114E-6
hyperphosphatasia with mental retardation,Adult,2.7685508131510595E-7
hyperphosphatasia with mental retardation,Tented mouth,0.06666666666666667
hyperphosphatasia with mental retardation,molecular genetic abnormality,3.0007501875468866E-5
hyperphosphatasia with mental retardation,Biologic Development,4.823205405848619E-6
hyperphosphatasia with mental retardation,congenital disorders of glycosylation,0.003745318352059925
hyperphosphatasia with mental retardation,bloods (ethnic group),4.209161661271925E-6
hyperphosphatasia with mental retardation,Biological Processes,2.2679851220175995E-5
hyperphosphatasia with mental retardation,PGAP2,0.23529411764705882
hyperphosphatasia with mental retardation,type in congenital disorder of glycosylation,0.002044989775051125
hyperphosphatasia with mental retardation,cellular targeting,2.869876910979288E-6
hyperphosphatasia with mental retardation,Play,1.4432409418590388E-6
hyperphosphatasia with mental retardation,membrane raft,1.7322016282695306E-4
hyperphosphatasia with mental retardation,congenital malformation syndrome,0.007462686567164179
hyperphosphatasia with mental retardation,granulocyte,6.168650916044661E-5
hyperphosphatasia with mental retardation,Cell surface,2.9395049873601284E-5
CWH43,Drosophila melanogaster,2.7826474107465842E-5
CWH43,deafness-hypogonadism syndrome,7.199424046076314E-4
CWH43,Does play,1.4418446383565279E-6
CWH43,Transfection,6.512239754618806E-6
CWH43,Lipid Metabolism,2.12021626205873E-5
CWH43,gene deletion abnormality,1.2477151216834172E-5
CWH43,Transcription, Genetic,2.151958389732576E-6
CWH43,Specimen,9.616660672281514E-7
CWH43,SPAM1,1.7220595832615808E-4
CWH43,Cell Wall,8.994962820820341E-5
CWH43,integration (data processing),1.1228259282963362E-5
CWH43,CWH43,1.0
CWH43,,0.0012674271229404308
CWH43,Exclusion,4.7158911383689615E-6
CWH43,Suppressor,3.6532349395389616E-5
CWH43,Mucous Membrane,8.843766029325928E-6
CWH43,Cells,2.0349316364716726E-6
CWH43,Mammalian Cell,2.361330846064842E-5
CWH43,numb (emotional response),8.884016499395443E-7
CWH43,cell cycle progression,7.561436672967863E-5
CWH43,member,4.1208394974224145E-6
CWH43,gene expression profiles,1.0235205011156373E-5
CWH43,Metabolic Inhibition,8.538324268479068E-7
CWH43,Cell Cycle,8.377384413038561E-6
CWH43,Laboratory Procedures,6.461926972470899E-7
CWH43,Cell division,6.240093851011519E-6
CWH43,Patient Discharge,1.6346333027112028E-6
CWH43,signal transduction pathways,1.5946038605359465E-5
CWH43,,1.5153811183512653E-4
CWH43,Tissue membrane,5.750960410388535E-6
CWH43,establishment and maintenance of position,5.315332075371409E-6
CWH43,PROTEIN KINASE,1.3589910850184822E-5
CWH43,genetic analysis,5.098399102681758E-5
CWH43,Cell membrane,4.400924194080757E-6
CWH43,Caenorhabditis elegans,4.623422257154746E-5
CWH43,,3.73366521468575E-4
CWH43,deacylation,6.711409395973154E-4
CWH43,Lysis,2.42101440503571E-5
CWH43,Stimulation (motivation),1.3995252810246764E-6
CWH43,Lower (action),9.55247148706667E-7
CWH43,sharing (social behavior),5.53703724211249E-6
CWH43,Conserved Sequence,3.109549426288131E-5
CWH43,Resistance (Psychotherapeutic),3.41917748266477E-6
CWH43,general (procedure) toxicology screen,2.687760208785213E-6
CWH43,Protein Binding,4.9769319205482585E-6
CWH43,Concentrate (substance),1.2726046399165171E-5
CWH43,,8.391162427731114E-6
CWH43,Disease regression,6.6736517555040945E-6
CWH43,oligonucleotide array sequence analysis,1.848633859577772E-5
CWH43,Cell Proliferation,5.142498637237861E-6
CWH43,regression - mental defense mechanism,7.229821568003702E-6
CWH43,Saccharomycetales,1.2124151309408342E-4
CWH43,IL6R,7.385524372230429E-4
CWH43,CLN3,0.0033783783783783786
CWH43,Endoplasmic Reticulum,2.2840958406614743E-5
CWH43,,2.3866348448687351E-4
CWH43,,0.005154639175257732
CWH43,cyclin-dependent protein kinase regulator activity,3.538946101850869E-5
CWH43,,5.677624481916766E-5
CWH43,Mammals,1.0777139531625515E-5
CWH43,mitotic cell cycle,8.428789372982359E-6
CWH43,Protein Overexpression,1.3129907302854442E-5
CWH43,Fusion procedure,5.52761041401802E-6
CWH43,Mutation Abnormality,4.021458502569712E-6
CWH43,Pgap2,0.13333333333333333
CWH43,Experimental Finding,7.981581702064316E-7
CWH43,Anchoring procedure,9.09008271975275E-5
CWH43,anchoring activity,9.09090909090909E-5
CWH43,Oncogenes,2.022653721682848E-5
CWH43,meta analysis (statistical procedure),1.7485574401119076E-5
CWH43,Temperature,2.740176467364498E-6
CWH43,Mental blocking,2.6695640334976896E-6
CWH43,classification,5.453603468491806E-6
CWH43,Event,2.5321648236727026E-6
CWH43,Phosphorylation,5.061702149198733E-6
CWH43,bioformation,3.468669245044139E-5
CWH43,Muscle strain,2.2519530062446657E-6
CWH43,sequence homology, amino acid,1.0118589873315255E-5
CWH43,Alleles,5.765416724320834E-6
CWH43,Straining,2.253018481510604E-6
CWH43,protein sequence determination,6.92583127289853E-6
CWH43,carcinoma of the large intestine,1.6182015308186483E-5
CWH43,binding (molecular function),1.3080342077106E-6
CWH43,Colorectal Neoplasms,1.9095266283488324E-5
CWH43,Measures,6.212171756609595E-7
CWH43,Protein Glycosylation,2.367256113438913E-5
CWH43,,1.2414649286157667E-4
CWH43,up-regulation (physiology),7.5620084694494855E-6
CWH43,genetic screening (procedure),1.5875535799333228E-4
CWH43,Microarray Analysis,9.979940319956887E-6
CWH43,,5.991611743559018E-4
CWH43,Surgical Replantation,9.25077937816261E-6
CWH43,Introduction procedure,7.672948253636978E-6
CWH43,Xerocytosis,6.954102920723226E-4
CWH43,Wild Type,9.548818333731201E-6
CWH43,Bacillus megaterium,5.991611743559018E-4
CWH43,glycosylation,2.3952669525018563E-5
CWH43,social resistance,3.4186982280887084E-6
CWH43,Protein Domain,7.548822006325913E-6
CWH43,classification of information,5.691487242531346E-6
CWH43,Tissue Growth,1.632421190785962E-6
CWH43,Visual Suppression,7.143163278426218E-6
CWH43,Deletion Abnormality,1.41008918814115E-5
CWH43,Doubling,5.4023100277678735E-6
CWH43,Encode (action),3.06723062813816E-6
CWH43,Metabolic Suppression,7.144592258119829E-6
CWH43,,5.143768324674657E-5
CWH43,personal status - adopted,1.0285949393128985E-5
CWH43,protein expression,1.176843024439499E-6
CWH43,mitogen-activated protein,1.7159722698881187E-5
CWH43,BBS9,6.484243288808196E-5
CWH43,research,1.6004045822783999E-6
CWH43,,2.7184993883376375E-5
CWH43,Biochemical Pathway,4.024493064792326E-6
CWH43,Mutant,1.2628136118679223E-5
CWH43,intact cell,7.679901697258276E-5
CWH43,,1.1852554225435582E-4
CWH43,,1.520091813545538E-5
CWH43,Cytoplasmic matrix,9.80084679316293E-6
CWH43,Colorectal Cancer,1.929123984798503E-5
CWH43,Play,1.443245107759896E-6
CWH43,Transition (action),5.5727071096597305E-6
CWH43,Signal Peptides,2.9474180617778827E-5
CWH43,Signal Pathways,1.8705224369166307E-5
CWH43,Protoplasm,6.724610392885362E-6
CWH43,candidate disease gene,1.54375781527394E-5
CWH43,Signal Transduction,1.3494275053808422E-6
CWH43,Eukaryotic Cells,2.1910124668609365E-5
CWH43,Sequence Alignment,2.3277738334943376E-5
CWH43,Epistasis, Genetic,2.477700693756194E-4
CWH43,,3.972983710766786E-4
CWH43,Block Specimens,2.669143631957123E-6
CWH43,Genes,3.614499202099301E-6
CWH43,Dividing cell,2.466091245376079E-4
CWH43,Anabolism,2.0816008343056145E-6
CWH43,Deletion Mutation,1.3862031203432239E-5
CWH43,Branch of,1.1258472000180136E-5
CWH43,In Vitro,1.333938051916869E-6
CWH43,pathologic cytolysis,2.9239766081871346E-5
CWH43,cDNA Arrays,1.3635124079629124E-4
CWH43,absence (morphologic abnormality),2.3509608376943656E-6
CWH43,DNM1L,6.501950585175553E-5
CWH43,Trichoderma,5.312084993359894E-4
CWH43,Synthesis activity,4.621363949356013E-6
CWH43,Catalysis,4.744643297716878E-6
CWH43,Disease Screening,2.6857245682026325E-6
CWH43,,1.156737998843262E-4
CWH43,,6.195786864931846E-4
CWH43,bud - plant part,6.330716637123322E-5
CWH43,nucleotide transition abnormality,5.559076303881347E-6
CWH43,nevus of ota,3.2351989647363315E-4
CWH43,Microsomes,3.675930010292604E-5
CWH43,sugar porter activity,0.002036659877800407
CWH43,,5.035246727089627E-4
CWH43,Saturated,1.2536512592926899E-5
CWH43,Growth action,1.6361845485275975E-6
CWH43,Cloning,4.056054675617027E-6
CWH43,Clone Cells,3.774795689183323E-6
CWH43,Discharge (release),2.10068146106597E-6
CWH43,exchange,8.002624860954394E-6
CWH43,in vivo,1.6705004652343796E-6
CWH43,encoding mental process,3.0674564344499896E-6
CWH43,fully spanning the plasma membrane,2.0769726047313437E-5
CWH43,encounter for genetic screening nec in icd9cm,1.6108247422680412E-4
CWH43,Cloning, Molecular,6.235813524232372E-6
CWH43,Homologous Gene,9.872496705054225E-6
CWH43,Eukaryota,2.7583163237160036E-5
CWH43,Incubated,9.749439407234085E-6
CWH43,genetic complementation test,5.6721497447532616E-5
CWH43,amino acid sequence,6.927734492266339E-6
CWH43,,5.087936502552448E-5
CWH43,Animals,2.3469374344030987E-7
CWH43,Genes, Suppressor,3.204101249599487E-4
CWH43,saccharomyces cerevisiae (fungus),3.2586876613050394E-5
CWH43,DNA Sequence,1.548459824435625E-6
CWH43,Deletion (action),1.2371950314247537E-5
CWH43,cdna microarray procedure,1.7143836790673754E-4
CWH43,Meta-Analysis,1.9893371528606668E-5
CWH43,Release (procedure),2.100478488999794E-6
CWH43,biological neural networks,4.6483521591595777E-5
CWH43,,0.005714285714285714
CWH43,defects,4.453152832205201E-6
CWH43,,2.372310393091832E-5
CWH43,Clone,3.682576625213129E-6
CWH43,GUCA2B,0.021739130434782608
CWH43,Gene Order,1.3349352556401014E-4
CWH43,Hypersensitivity,1.342552191716453E-5
CWH43,Melanogaster,2.0863759649488838E-4
CWH43,Screening procedure,2.65013687956983E-6
CWH43,Decision Trees,9.706853038245001E-5
CWH43,Obstruction,2.0391558710356262E-6
CWH43,Phenotype,5.76481846586651E-6
CWH43,gene expression profiling,1.167051793758607E-5
CWH43,Assay,1.7344910482916997E-6
CWH43,enzymology,1.6893632620928846E-6
CWH43,Growth arrest,9.656237929702588E-5
CWH43,Growth,1.6358499794700827E-6
CWH43,open reading frames,1.069438651651748E-5
CWH43,in vitro assay,7.481110196753198E-5
CWH43,Trees (plant),1.6212973621491917E-5
CWH43,Activation action,1.1072909573083972E-6
CWH43,,0.003484320557491289
CWH43,budding (cell function),6.356470887363335E-5
CWH43,Base Sequence,1.1847863948608706E-6
CWH43,molecular sequence data,4.973944819056178E-6
CWH43,integral to membrane,2.075980900975711E-5
CWH43,metaplastic cell transformation,4.610610859832819E-6
CWH43,mRNA Expression,1.174868620316533E-6
CWH43,,0.02631578947368421
CWH43,,3.7758646730101195E-5
CWH43,Unable,3.0058463711919685E-5
CWH43,Rat Osteosarcoma,0.0017730496453900709
CWH43,incorporation,9.609471094710947E-6
CWH43,,1.3383297644539615E-4
CWH43,Transcriptional Activation,7.205181966870573E-6
CWH43,,0.014084507042253521
CWH43,normal assessment finding,2.0135593083826487E-6
CWH43,DNA Integration,1.1191440786086801E-5
CWH43,AQP8,0.004830917874396135
CWH43,,1.4498216719343522E-5
CWH43,branch of plant,1.0861537124733893E-5
CWH43,sampling - surgical action,1.1377742178086697E-6
CWH43,amino acid motifs,4.8716324840454034E-5
CWH43,Gene Deletion,2.5333772452055837E-5
CWH43,Schizosaccharomyces pombe,1.0270103728047654E-4
CWH43,TCN1,0.0036363636363636364
CWH43,Neck,1.677796047112513E-5
CWH43,radioisotopic labeling (lab procedure),2.6732249786142E-5
CWH43,Organism Strain,2.2536226984878193E-6
CWH43,Activities,6.301852429521658E-7
CWH43,PGAP2,0.1875
CWH43,Necking (finding),1.6850619260257815E-5
CWH43,Substitution - change,9.73065545695158E-6
CWH43,fibroblast growth factor binding,5.717552887364208E-5
CWH43,,0.003861003861003861
CWH43,Psychological suppression,7.150620673874493E-6
